Bellevue Healthcare Trust seeks shareholder approval for share buybacks

Published 26/06/2025, 08:04
Bellevue Healthcare Trust seeks shareholder approval for share buybacks

LONDON - Bellevue Healthcare Trust plc announced on Thursday that it will hold a General Meeting on July 15, 2025, to seek shareholder approval for additional share repurchase authority to support its Zero Discount Policy.

The meeting, scheduled for 9:00 a.m. at The Shard in London, comes after the company introduced the policy on April 23, 2025, with the aim of maintaining a share price that trades at or around net asset value in normal market conditions.

Since implementing the policy, Bellevue has repurchased 57,155,469 shares, with its stock trading at an average discount to net asset value of 1.3 percent, according to a company press release.

The trust is seeking the new authorization as the current share repurchase authority, approved at a general meeting on June 13, 2025, may soon be fully utilized. Without this additional authority, the company stated it may lack sufficient capacity to continue supporting its Zero Discount Policy through share buybacks.

Shareholders can submit proxy appointments until 9:00 a.m. on July 11, 2025. The company noted that photo identification will be required for those attending the meeting in person.

A circular containing the meeting notice will be available on the National Storage Mechanism and the company’s website.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.